Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 May 1;50(5):819-824.
doi: 10.1097/CCM.0000000000005451. Epub 2022 Feb 21.

A Retrospective Observational Study Exploring 30- and 90-Day Outcomes for Patients With COVID-19 After Percutaneous Tracheostomy and Gastrostomy Placement

Affiliations
Observational Study

A Retrospective Observational Study Exploring 30- and 90-Day Outcomes for Patients With COVID-19 After Percutaneous Tracheostomy and Gastrostomy Placement

Stephanie B Kiser et al. Crit Care Med. .

Abstract

Objectives: To determine the 30- and 90-day outcomes of COVID-19 patients receiving tracheostomy and percutaneous endoscopic gastrostomy (PEG).

Design: Retrospective observational study.

Setting: Multisite, inpatient.

Patients: Hospitalized COVID-19 patients who received tracheostomy and PEG at four Boston hospitals.

Interventions: Tracheostomy and PEG placement.

Measurements and main results: The primary outcome was mortality at 30 and 90 days post-procedure. Secondary outcomes included continued device presence, place of residence, complications, and rehospitalizations. Eighty-one COVID-19 patients with tracheostomy and PEG placement were included. At 90 days post-device placement, the mortality rate was 9.9%, 2.7% still had the tracheostomy, 32.9% still had the PEG, and 58.9% were at home.

Conclusions: More than nine-in-10 patients in our population of COVID-19 patients who underwent tracheostomy and PEG were alive 90 days later and most were living at home. This study provides new information regarding the outcomes of this patient population that may serve as a step in guiding clinicians, patients, and families when making decisions regarding these devices.

PubMed Disclaimer

Conflict of interest statement

Dr. Leiter received funding from the New England Journal of Medicine, New York University, the New York Times, and the United States Uniformed Services University. Dr. Mazzola received funding from The VeraMedica Institute LLC. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Figures

Figure 1.
Figure 1.
Ninety-day outcomes in terms of mortality, place of residence, and presence of device, for patients who underwent combined tracheostomy and percutaneous endoscopic gastrostomy (PEG).

Comment in

References

    1. Johns Hopkins Coronavirus Resource Center: COVID-19 Map. 2020. Available at: https://coronavirus.jhu.edu/map.html. Accessed January 4, 2021
    1. Richardson S, Hirsch JS, Narasimhan M, et al. ; the Northwell COVID-19 Research Consortium: Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020; 323:2052–2059 - PMC - PubMed
    1. McCarthy CP, Murphy S, Jones-O’Connor M, et al. : Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system. EClinicalMedicine. 2020; 26:100504. - PMC - PubMed
    1. Armstrong RA, Kane AD, Cook TM: Outcomes from intensive care in patients with COVID-19: A systematic review and meta-analysis of observational studies. Anaesthesia. 2020; 75:1340–1349 - PubMed
    1. Grasselli G, Greco M, Zanella A, et al. ; COVID-19 Lombardy ICU Network: Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020; 180:1345–1355 - PMC - PubMed

Publication types